Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Ames National | ATLO | Oct 18, 2024 | 18.15 | -0.06 |
Amesite | AMST | Oct 18, 2024 | 2.57 | +1.58 |
Ametek | AME | Oct 18, 2024 | 169.40 | -0.17 |
Amgen | AMGN | Oct 18, 2024 | 321.66 | +0.10 |
Amicus Therapeutics | FOLD | Oct 18, 2024 | 11.90 | -0.58 |
Amkor Technology | AMKR | Oct 18, 2024 | 30.53 | -1.36 |
AMMO | POWW | Oct 18, 2024 | 1.28 | +1.59 |
AMMO A Pref | POWWP | Oct 18, 2024 | 22.23 | +0.99 |
AMN Healthcare Services | AMN | Oct 18, 2024 | 41.01 | -3.32 |
Amneal Pharmaceuticals A | AMRX | Oct 18, 2024 | 8.58 | +1.42 |
Ampco-Pittsburgh | AP | Oct 18, 2024 | 1.97 | +8.84 |
Amphastar Pharmaceuticals | AMPH | Oct 18, 2024 | 50.84 | +2.27 |
Amphenol | APH | Oct 18, 2024 | 67.46 | -0.12 |
Amplify Energy | AMPY | Oct 18, 2024 | 6.55 | -2.09 |
Amplify Online Retail ETF | IBUY | Oct 18, 2024 | 62.09 | +0.39 |
Amplify Transformational Data Sharing ETF | BLOK | Oct 18, 2024 | 40.90 | +2.79 |
Amplitech Group | AMPG | Oct 18, 2024 | 0.84 | -4.03 |
Amplitude A | AMPL | Oct 18, 2024 | 9.02 | +0.89 |
Amprius Technologies | AMPX | Oct 18, 2024 | 1.40 | +7.69 |
AMREP | AXR | Oct 18, 2024 | 29.54 | +5.88 |
AMTD Digital ADR | HKD | Oct 18, 2024 | 3.64 | +1.39 |
AMTD Idea Group ADR | AMTD | Oct 18, 2024 | 1.41 | +2.17 |
Amtech Systems | ASYS | Oct 18, 2024 | 5.72 | -1.55 |
Amylyx Pharmaceuticals | AMLX | Oct 18, 2024 | 4.78 | +21.94 |
AN2 Therapeutics | ANTX | Oct 18, 2024 | 1.05 | +1.94 |
Analog Devices | ADI | Oct 18, 2024 | 228.33 | +0.44 |
AnaptysBio | ANAB | Oct 18, 2024 | 34.98 | -0.57 |
Anavex Life Sciences | AVXL | Oct 18, 2024 | 5.65 | +2.63 |
Andretti Acquisition II Unit | POLEU | Oct 18, 2024 | 9.95 | 0.00 |
Anebulo Pharmaceuticals | ANEB | Oct 18, 2024 | 1.96 | +7.18 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.